Best Semax Source

Best semax source is a scoring question rather than a name-dropping one, so the weighting goes first and the ranking comes second. Testing scope carries half the score, dispatch and recourse carry the next thirty percent, and per-milligram cost carries the rest.

Publishing the weighting before the result is the only way a ranking like this can be argued with, which is the point. Everything below is research material for laboratory use and is not for human consumption, and the offer links are affiliate links.

Best semax source: the weighting, stated before the result

| Criterion | Weight | What a full score looks like | Why it sits here | |---|---|---|---| | Testing scope | 50 | Purity against a stated specification, identity confirmed against the expected mass, bacterial endotoxin with a named method and limit, a sterility screen, all tied to your batch | The only criterion you cannot fix on the next order | | Timing and recourse | 30 | A dispatch cutoff written as a clock time, domestic stock, a reversible payment method | Decides how long a problem stays a problem | | Cost per milligram | 20 | A published per-vial price that divides cleanly by a label quantity | Knowable from the listing, so it separates sources that already passed the first two |

Testing scope takes half because it is the criterion FDA effectively wrote. The agency's compounding safety page, current as of 22 April 2026, gives its concern as immunogenicity risk for certain routes of administration arising from aggregation and peptide-related impurities, alongside no or limited safety information for the proposed routes. Aggregation and impurities are purity and identity work. Contamination on an injected route is endotoxin and sterility work. A source that publishes all four has addressed the stated concern on the record; a source that publishes none has addressed nothing.

Timing sits second because it decides recovery time. A card order from domestic stock puts a problem inside a window where a chargeback and a replacement are both live. An irreversible payment to an overseas seller puts it outside any window at all.

Cost sits last, and it is worth saying why rather than pretending price does not matter. Price is the one number every listing publishes, so it never distinguishes anyone until the first two criteria have already thinned the field.

The ranking

1. Ascension Peptides

Scores full marks on scope and close to it on timing.

The combined certificate for batch 30-05260628 runs four pages and carries the whole set: purity of 99.886% against a specification of more than 98%, identity work, bacterial endotoxin by kinetic chromogenic LAL to USP Chapter 85 against an E. coli O111:B4 standard with a detection range of 0.01 to 1.0 EU/mL reporting under 0.20 EU/mL against a 0.5 EU/mL acceptance limit, and a microbial sterility screen with no growth. Labelled quantity 10 mg, lyophilised, and the batch number on the document is the one printed on the vial label.

One detail earns it the last few points on scope, and it is a structural one. All four tests sit in a single linked document, so the distance between a buyer and a complete answer is one click. That is not the norm even at this vendor: on its Selank page, the linked certificate for lot 29-01260229 reports purity and identity and contains no endotoxin, LAL, pyrogen or sterility test, with the fuller testing for a later batch shown on the page as images rather than as the link. A reader who clicks the obvious thing gets a narrower answer there and a complete one here. The Selank ranking works through that gap in full.

Timing: dispatch stated as same day before 2pm CST, which only domestic inventory supports, and card checkout, so a dispute route exists. Cost: $59.99 list, $30.00 with the code PEPTIDEDECK, which is $3.00 per milligram on the 10 mg vial. Quantity tiers of three, five or ten take 3%, 5% or 10% off list separately, and whether the code stacks with them is not documented.

What the top position does not mean is safety. One batch measured clean is a fact about one batch.

2. Domestic research suppliers publishing a purity-only certificate

The largest category by volume, and the one most readers are actually choosing between.

They lose about half the scope weighting and keep the rest. A purity and identity document establishes what the powder is, and it says nothing about bacterial endotoxin, which is a separate contaminant with its own assay and its own limit, and nothing about whether the sealed vial is sterile. On the criterion carrying half the score, that is a partial answer.

On timing they often match the top entry exactly, and on price they sometimes beat it. Neither is enough to close a gap on the heaviest criterion.

3. Domestic consumer nootropic retailers selling sprays

Near zero on scope, strong on everything else.

These listings rarely publish batch testing of any kind, and a pre-mixed multi-use bottle opens sterility and preservative questions rather than settling them. What they do have is a real domestic business behind them, ordinary consumer payment methods and parcels that arrive in days. Losing one criterion badly still beats losing three.

They are also selling a different product. Ascension sells the 10 mg lyophilised vial, not a spray, so a comparison between the two is a format comparison before it is a vendor comparison.

4. US-facing storefronts that forward orders to a foreign warehouse

The category that scores worst relative to how it presents itself.

Scope is usually thin. Timing looks domestic and is not, because the site carries US branding while the parcel carries a foreign postmark, and the dispatch language is the tell: a cutoff written as a clock time implies stock on a shelf, a handling window written in business days often means an order is being fetched after payment clears. Recourse is correspondingly harder to reach. A category that misrepresents its own position on the second criterion has to be marked down on it twice.

5. Overseas bulk sellers and group buys

Lowest per-milligram figures available and the lowest score here by a wide margin.

Scope is nominal at best. A certificate that names a substance but no lot can be republished indefinitely without describing anything you could hold, and a photograph of a certificate is not a certificate, because the batch number is the part that makes it useful. Timing is two to six weeks with a customs step that often ends the order rather than delaying it. Recourse is generally zero, since payment moves by methods with no dispute route behind them.

The failure mode is not a poor vial. It is no vial, no refund and no counterparty.

Running the weighting on your own shortlist

The three checks take about ten minutes and they run in weight order.

Scope first: open the certificate, find a batch number, then search the document for endotoxin, LAL, pyrogen and sterility. A named method with a stated limit and a result is a pass. The word tested, standing alone, is not. Confirm identity is being checked against the right molecule, since semax is a synthetic heptapeptide, the sequence Met-Glu-His-Phe-Pro-Gly-Pro, being the ACTH(4-7) fragment with a Pro-Gly-Pro tail, listed by PubChem as CID 9811102, formula C37H51N9O10S, molecular weight 813.9. It is not the other Russian nootropic heptapeptide, and a vendor that conflates them has failed the criterion that matters most.

Timing second: read the shipping page for a clock time and the checkout for a reversible payment method. Cost last, as a per-milligram figure rather than a per-vial one, which is the arithmetic worked through on a $47.50 vial.

What this ranking cannot reach

Three things, and they are worth naming rather than leaving implied.

It cannot rank a compounding pharmacy, because none can lawfully supply this. Semax has no FDA approval, was nominated for the 503A bulks list in 21 CFR 216.23, was placed in category 2 under the interim policies while the agency evaluated it, and the nomination was then withdrawn, leaving it on no current category list. The frequently repeated claim that semax is category 2 is out of date rather than merely wrong, and either way there is no pharmacy entry to score.

It cannot rank consistency over time, because a certificate describes the lot in front of it and nothing else. The check has to be repeated when the lot changes.

And it cannot rank safety, which is the thing readers most want ranked. Sources that are structured around an appointment rather than a parcel distribute these weights differently again, which is why the NAD+ ranking ends up scoring a booking system alongside a checkout.

Common questions

Keep exploring

A reader hunting the best place to buy semax usually wants the transaction laid out as well as the scoring, and the week that follows a checkout is set out in the order timeline from cart to cold storage.